user avatar
Prof Kausik Ray FMedSci
@ProfKausikRay
Immediate Past President EAS, Professor of Public Health, Imperial College London. Cardiologist focusing on preventing coronary artery disease
London, England
kausikray.com
Joined February 2018
1,073
Following
6,205
Followers
Posts
  • user avatar
    Prof Kausik Ray FMedSci
    @ProfKausikRay
    Jan 1, 2021
    Today I start the Presidency of the European Atherosclerosis Society for 4 years with big shoes to fill and a challenging landscape. With the fantastic EC and office as well as collaboration of global colleagues and friends I hope to continue the success of those before me
  • user avatar
    Prof Kausik Ray FMedSci
    @ProfKausikRay
    Nov 7, 2022
    OTC supplements claiming to offer cholesterol lowering. Vs a low dose statin in primary prevention. Overall reduction, individual response and safety . Best trial this year
  • user avatar
    Prof Kausik Ray FMedSci
    @ProfKausikRay
    Oct 1, 2019
    So I have just been notified that I was elected to the office of President Elect of the European Atherosclerosis Society from Jan 2020 to start a 4 year term from 2021. Thanks for the support and lots to do
  • user avatar
    Prof Kausik Ray FMedSci
    @ProfKausikRay
    Nov 4, 2022
    Timely for the AHA . New inclisiran data on MACE
  • user avatar
    Prof Kausik Ray FMedSci
    @ProfKausikRay
    Nov 15, 2020
    Our paper out now in JAMA . Lots to discuss heh jamanetwork.com/journals/jama/…
  • user avatar
    Prof Kausik Ray FMedSci
    @ProfKausikRay
    Oct 13, 2021
    Step wise approaches delay intensification of treatment 👇 this is pragmatic and more likely to achieve goals for the right patients earlier
  • user avatar
    Prof Kausik Ray FMedSci
    @ProfKausikRay
    Sep 16, 2021
    So today the first UK patient outside of clinical trials received a dose of inclisiran in my clinic. The first but not the last. A small step for a man but a giant leap for mankind. Sorry not sorry but couldn’t think of anything better….
  • user avatar
    Prof Kausik Ray FMedSci
    @ProfKausikRay
    Apr 6, 2022
    Well this is a pleasant surprise. Particularly as a non-American……to receive this award from the prestigious US National Lipid Association is a real honour. Looking forward to visiting Scottsdale in June to see US friends and colleagues and to receive this
  • user avatar
    Prof Kausik Ray FMedSci
    @ProfKausikRay
    Jan 5, 2023
    Well here it is. ORION 3! Inclisiran OLE. Happy NYE. Open access LancetDiabetes with an editorial by @ProfSNicholls authors.elsevier.com/sd/article/S22…
    29K
  • user avatar
    Prof Kausik Ray FMedSci
    @ProfKausikRay
    Sep 2, 2019
    Our paper in JAMA . Lifetime LDL and BP reduction reduces lifetime risk of CVD by nearly 80 %
  • user avatar
    Prof Kausik Ray FMedSci
    @ProfKausikRay
    Dec 13, 2023
    8 years of work & the trilogy is complete. The largest global dataset on FH ever and the most impactful initiative since Medped in the 90s. Children with FH can be identified by cholesterol levels from year 2 of life if we start to screen
    19K
  • user avatar
    Prof Kausik Ray FMedSci
    @ProfKausikRay
    Apr 14, 2025
    Since 2016 and the Improve It trial we have known that two drugs statins and ezetimibe combination therapy were better than statin monotherapy after an MI for CVD prevention. We also have had PCSK9i trials showing other combination therapies also reduce CVD when added to statins.
    14K
  • user avatar
    Prof Kausik Ray FMedSci
    @ProfKausikRay
    Sep 1, 2021
    Inclisiran is now available in the uk
  • user avatar
    Prof Kausik Ray FMedSci
    @ProfKausikRay
    Dec 27, 2019